Echo Biotech Secures Series A++ Funding for Exosomes Drug Development
Echo Biotech, a Beijing-based exosomes drug developer, has reportedly raised “tens of millions” of renminbi...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity